Pancreatic Cancer Research

ResearcherFujian Medical UniversityActive in the last 2 years

Ronggui Lin

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5110725474. Sources: OpenAlex.

Their work

Papers
12 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
24
Papers, trials and grants by year

2020: 2 papers · 2021: 2 papers · 2022: none · 2023: 2 papers · 2024: 3 papers · 2025: 1 paper · 2026: 2 papers

Papers 12

  1. Genetic evaluation of encorafenib-associated kinases RAF1 and MAPK8 in pancreatic cancer: Exploratory mediation by circulating immune traits. Co-author DOI 10.1016/j.tranon.2026.103040↗
  2. Cancer antigen 125 levels change rule after laparoscopic biopsy and its prognostic value for patients with unresectable pancreatic ductal adenocarcinoma: a ret… Co-author DOI 10.1186/s12876-026-04688-7↗
  3. An exploratory study of serum creatine kinase as a prognostic marker for patients with resectable pancreatic cancer: looking into the relationship with body co… Co-author DOI 10.1186/s12937-025-01084-x↗
  4. Pirfenidone antagonizes TGF-β1-mediated gabapentin resistance via reversal of desmoplasia and the 'cold' microenvironment in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2024.217287↗
  5. The combined effect of hypoxia activation and radiosensitization by a multifunctional nanoplatform system enhances the therapeutic efficacy of chemoradiotherap… Last author DOI 10.1016/j.pan.2024.11.003↗
  6. Mitochondria-Targeting Virus-Like Gold Nanoparticles Enhance Chemophototherapeutic Efficacy Against Pancreatic Cancer in a Xenograft Mouse Model. Co-author DOI 10.2147/ijn.s497346↗
  7. The CA125 level postoperative change rule and its prognostic significance in patients with resectable pancreatic cancer. Co-author DOI 10.1186/s12885-023-11346-8↗
  8. A high serum creatine kinase (CK)-MB-to-total-CK ratio in patients with pancreatic cancer: a novel application of a traditional marker in predicting malignancy… Co-author DOI 10.1186/s12957-023-02903-3↗
  9. Laparoscopic biopsy and staging for locally advanced pancreatic cancer: experiences of 76 consecutive patients in a single institution. First author DOI 10.1007/s00423-021-02199-5↗
  10. Selecting surgical candidates with locally advanced pancreatic cancer: a review for modern pancreatology. Co-author DOI 10.21037/jgo-21-119↗
  11. High-dimensional single-cell analysis delineates radiofrequency ablation induced immune microenvironmental remodeling in pancreatic cancer. Co-author DOI 10.1038/s41419-020-02787-1↗
  12. Photothermal augment stromal disrupting effects for enhanced Abraxane synergy chemotherapy in pancreatic cancer PDX mode. First author DOI 10.1039/d0bm00549e↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xianchao Lin · 7 shared papers, 2020–2026 · strength 1.35
  2. Fengchun Lu · 6 shared papers, 2020–2026 · strength 1.23
  3. Heguang Huang · 6 shared papers, 2020–2025 · strength 1.14
  4. Congfei Wang · 4 shared papers, 2021–2026 · strength 0.89
  5. Cong Chen · 3 shared papers, 2023–2026 · strength 0.80
  6. Tianhong Teng · 4 shared papers, 2020–2025 · strength 0.77
  7. Xin Luo · 2 shared papers, 2023–2026 · strength 0.51
  8. Heguang Huang · 2 shared papers, 2020–2024 · strength 0.40
  9. Maoen Pan · 2 shared papers, 2020–2024 · strength 0.40
  10. Shiyun Lu · 1 shared paper, 2026 · strength 0.36
  11. Fen Lin · 1 shared paper, 2026 · strength 0.36
  12. Zongqi Weng · 1 shared paper, 2026 · strength 0.36
  13. Yue Wu · 1 shared paper, 2026 · strength 0.32
  14. Jin Zhang · 1 shared paper, 2024 · strength 0.22
  15. Bing Chen · 1 shared paper, 2024 · strength 0.19
  16. Yanbin Meng · 1 shared paper, 2024 · strength 0.19
  17. Y. H. Andrew Wu · 1 shared paper, 2021 · strength 0.15
  18. Shuichi Watanabe · 1 shared paper, 2021 · strength 0.15
  19. Atsushi Oba · 1 shared paper, 2021 · strength 0.15
  20. Marco Del Chiaro · 1 shared paper, 2021 · strength 0.15
  21. Richard David Schulick · 1 shared paper, 2021 · strength 0.15
  22. Zelin Hou · 1 shared paper, 2020 · strength 0.10
  23. Qinglin Fei · 1 shared paper, 2020 · strength 0.10
  24. Yu Pan · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.